Table 2. Within and between group comparison of the performance outcomes of the citrus flavonoid group and placebo group, with corresponding p-values. Values are expressed as mean (± SEM).
Variables |
Citrus Flavonoid (CF) (n=19) |
Placebo (n=20) |
Test 1 |
Test 2 |
∆T2-T1 |
< P1† |
Test 1 |
Test 2 |
∆T2-T1 |
<P2‡ |
<P3§ |
Weight (kg) |
74.1 (1.8) |
74.2 (1.74) |
.1 (.1) |
.406 |
74.8 (1.9) |
74.7 (1.9) |
-.1 (.4) |
.718 |
.529 |
Abs P (W) |
298(11) |
313(10) |
14.9 (3.9) |
.001 |
301(11) |
304.3 (11.4) |
3.8 (3.2) |
.243 |
.032 |
Rel P (W·kg-1) |
4.0 (.1) |
4.2 (.1) |
.2 (.1) |
.002 |
4.0 (.2) |
4.1 (.1) |
.1 (.1) |
.328 |
.077 |
HR (BPM) |
170(4) |
169(3) |
-1(2) |
.578 |
176(3) |
177(3) |
1(1) |
.206 |
.276 |
Av VO2 |
51.1 (1.6) |
52.0 (1.2) |
.9 (.7) |
.235 |
49.6 (2.1) |
50.2 (1.8) |
.6 (.6) |
.330 |
.736 |
Es VO2max |
57.9 (1.6) |
57.9 (± 1.3) |
.0 (.7) |
.988 |
56.5 (1.8) |
56.7 (1.6) |
.2 (.9) |
.784 |
.826 |
VO2/Power ratio |
.176 (.005) |
.167 (.004) |
-.009 (.002) |
.001 |
.170 (.004) |
.171 (.004) |
.001 (.002) |
.534 |
.001 |
PP output (W) |
360(36) |
378(40) |
18(23) |
.444 |
307(22) |
279(20) |
-29(17) |
.123 |
.116 |
Abs P: Absolute power; Rel P: Relative power; HR: Heart rate; Av VO
2: Average VO
2 (mL·kg
-1·min
-1); Es VO
2max: Estimated VO
2max (mL·kg
-1·min
-1); PP output: Peak power output.† P1; P-value of within CF group differences between Test 2 and Test 1 (∆T2-T1); compared using a paired t-test‡P2; P-value of within placebo group differences between Test 2 and Test 1 (∆T2-T1); compared using a paired t-test§P3; P-value of the difference between pre- and post-treatment between the CF and placebo group using a mixed ANOVA.